🔎 Trials Near Me

Akèy › Kolit Ulseratif › Texas › Garland

Etid klinik pou Kolit Ulseratif nan Garland, TX

8 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Garland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 005, Garland
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-024, Garland
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Xencor Investigative Site, Garland
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • GI Alliance -Garland /ID# 284253, Garland
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07697456

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • GI Alliance - Garland, Garland
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • GI Alliance - Garland, Garland
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Ap rekriteFaz 3
  • GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
Tout laj · Tout sèks · Mizajou Sep 9, 2026 · NCT06651281

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Garland
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Garland

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.